UY31061A1 - Tratamiento de la degeneracion macular relacionada con la edad mediante el uso de inhibidores del factor d del complemento - Google Patents
Tratamiento de la degeneracion macular relacionada con la edad mediante el uso de inhibidores del factor d del complementoInfo
- Publication number
- UY31061A1 UY31061A1 UY31061A UY31061A UY31061A1 UY 31061 A1 UY31061 A1 UY 31061A1 UY 31061 A UY31061 A UY 31061A UY 31061 A UY31061 A UY 31061A UY 31061 A1 UY31061 A1 UY 31061A1
- Authority
- UY
- Uruguay
- Prior art keywords
- age
- treatment
- complement
- factor
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
El presente invento provee métodos para identificar a los pacientes en riesgo de contraer una degeneracion muscular relacionada con la edad mediante la identificacion de la presencia del polimorfismo Y402H u otra variante de riesgo en el gen factor H del complemento.Asimismo, el presente invento provee métodos para el tratamiento de personas con degeneracion muscular relacionada con la edad o en riesgo de desarrollar dicha enfermedad por la presencia del polimorfismo Y402H u otra variante de riesgo en el gen factor H del complemento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91487707P | 2007-04-30 | 2007-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31061A1 true UY31061A1 (es) | 2008-10-31 |
Family
ID=39586997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31061A UY31061A1 (es) | 2007-04-30 | 2008-04-29 | Tratamiento de la degeneracion macular relacionada con la edad mediante el uso de inhibidores del factor d del complemento |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080269318A1 (es) |
EP (1) | EP2139471A2 (es) |
JP (1) | JP2010526074A (es) |
KR (1) | KR20100014486A (es) |
CN (1) | CN101674824A (es) |
AR (1) | AR066292A1 (es) |
AU (1) | AU2008248043A1 (es) |
BR (1) | BRPI0811007A2 (es) |
CA (1) | CA2680833A1 (es) |
CL (1) | CL2008001259A1 (es) |
MX (1) | MX2009009738A (es) |
RU (1) | RU2009144142A (es) |
TW (1) | TW200900056A (es) |
UY (1) | UY31061A1 (es) |
WO (1) | WO2008137236A2 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2316394B1 (en) | 2001-06-12 | 2016-11-23 | The Johns Hopkins University | Reservoir device for intraocular drug delivery |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
SG173167A1 (en) | 2009-01-29 | 2011-08-29 | Forsight Labs Llc | Posterior segment drug delivery |
WO2013022801A1 (en) | 2011-08-05 | 2013-02-14 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
PT2600812T (pt) | 2010-08-05 | 2021-11-09 | Forsight Vision4 Inc | Aparelho para tratar um olho |
CN105435338B (zh) | 2010-08-05 | 2019-03-26 | 弗赛特影像4股份有限公司 | 用于药物输送的注入器装置和方法 |
AU2011329656B2 (en) | 2010-11-19 | 2017-01-05 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
RU2495650C1 (ru) * | 2012-02-29 | 2013-10-20 | Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации | Трехкомпонентный комплекс для клеточной терапии в офтальмологии |
RU2485922C1 (ru) * | 2012-03-28 | 2013-06-27 | Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения "сухой" формы возрастной макулярной дегенерации |
RU2494711C1 (ru) * | 2012-05-18 | 2013-10-10 | Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации | Способ хирургического лечения прогрессирующей и осложненной миопии |
US9968603B2 (en) | 2013-03-14 | 2018-05-15 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
EP2978393B1 (en) | 2013-03-28 | 2023-12-27 | ForSight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
MX2016001854A (es) * | 2013-08-12 | 2016-09-06 | Genentech Inc | Composiciones y metodo para tratar condiciones asociadas con el complemento. |
US11219552B2 (en) | 2013-09-06 | 2022-01-11 | The Regents Of The University Of Colorado, A Body Corporate | Intraocular filter device and methods of using same |
WO2015035296A2 (en) * | 2013-09-06 | 2015-03-12 | The Regents Of The University Of Colorado, A Body Corporate | Intraocular drug delivery and filter device and methods of using same |
US20160237146A1 (en) * | 2013-10-07 | 2016-08-18 | Massachusetts Eye And Ear Infirmary | Methods of Preventing or Reducing Photoreceptor Cell Death |
DE102014107380A1 (de) | 2014-05-26 | 2015-11-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Verfahren zur Diagnose einer durch den alternativen Weg des Komplementsystems vermittelten Krankheit oder eines Risikos hierfür |
DK3154561T3 (da) | 2014-06-12 | 2019-10-07 | Ra Pharmaceuticals Inc | Modulering af komplementaktivitet |
US9474756B2 (en) | 2014-08-08 | 2016-10-25 | Forsight Vision4, Inc. | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
LT3250230T (lt) | 2015-01-28 | 2021-12-27 | Ra Pharmaceuticals, Inc. | Komplemento aktyvumo moduliatoriai |
CA3005238A1 (en) | 2015-11-20 | 2017-05-26 | Forsight Vision4, Inc. | Porous structures for extended release drug delivery devices |
SG11201804721SA (en) | 2015-12-16 | 2018-07-30 | Ra Pharmaceuticals Inc | Modulators of complement activity |
EP3405577B8 (en) | 2016-01-20 | 2023-02-15 | 396419 B.C. Ltd. | Compositions and methods for inhibiting factor d |
JP7301741B2 (ja) | 2016-12-07 | 2023-07-03 | ラ ファーマシューティカルズ インコーポレイテッド | 補体活性のモジュレータ |
WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
EP3610010A4 (en) * | 2017-04-14 | 2021-02-24 | Kodiak Sciences Inc. | COMPLEMENT D-FACTOR ANTAGONIST ANTIBODIES AND THEIR CONJUGATES |
JP2021505565A (ja) | 2017-12-04 | 2021-02-18 | ラ ファーマシューティカルズ インコーポレイテッドRa Pharmaceuticals,Inc. | 補体活性のモジュレータ |
TW202100179A (zh) | 2019-03-08 | 2021-01-01 | 美商Ra製藥公司 | 補體活性之調節劑 |
WO2020205501A1 (en) | 2019-03-29 | 2020-10-08 | Ra Pharmaceuticals, Inc. | Complement modulators and related methods |
JP2022530042A (ja) | 2019-04-24 | 2022-06-27 | ラ ファーマシューティカルズ インコーポレイテッド | 補体活性を調節するための組成物及び方法 |
CN114786731A (zh) | 2019-10-10 | 2022-07-22 | 科达制药股份有限公司 | 治疗眼部病症的方法 |
MX2022014275A (es) | 2020-05-12 | 2022-12-07 | Alexion Pharma Inc | Uso de inhibidores del factor d del complemento solos o junto con anticuerpos anti-c5 para el tratamiento de la hemoglobinuria paroxistica nocturna. |
CN114686481B (zh) * | 2020-12-31 | 2023-08-15 | 北京键凯科技股份有限公司 | 一种抑制cfd表达的干扰rna及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7808198A (en) * | 1997-06-03 | 1998-12-21 | Biocryst Pharmaceuticals, Inc. | Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation |
AU775149B2 (en) * | 1999-10-21 | 2004-07-22 | Alcon Inc. | Sub-tenon drug delivery |
EP2026073B1 (en) * | 2000-04-29 | 2016-03-30 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
NZ595305A (en) * | 2005-02-14 | 2013-06-28 | Univ Iowa Res Found | Methods and reagents for treatment and diagnosis of age-related macular degeneration |
US8580735B2 (en) * | 2007-02-05 | 2013-11-12 | Apellis Pharmaceuticals, Inc. | Local complement inhibition for treatment of complement-mediated disorders |
-
2008
- 2008-04-07 JP JP2010506378A patent/JP2010526074A/ja not_active Withdrawn
- 2008-04-07 RU RU2009144142/15A patent/RU2009144142A/ru not_active Application Discontinuation
- 2008-04-07 CN CN200880014124A patent/CN101674824A/zh active Pending
- 2008-04-07 MX MX2009009738A patent/MX2009009738A/es unknown
- 2008-04-07 AU AU2008248043A patent/AU2008248043A1/en not_active Abandoned
- 2008-04-07 BR BRPI0811007-7A2A patent/BRPI0811007A2/pt not_active Application Discontinuation
- 2008-04-07 KR KR1020097019578A patent/KR20100014486A/ko not_active Application Discontinuation
- 2008-04-07 US US12/098,527 patent/US20080269318A1/en not_active Abandoned
- 2008-04-07 EP EP08733143A patent/EP2139471A2/en not_active Withdrawn
- 2008-04-07 WO PCT/US2008/059556 patent/WO2008137236A2/en active Application Filing
- 2008-04-07 CA CA002680833A patent/CA2680833A1/en not_active Abandoned
- 2008-04-24 AR ARP080101742A patent/AR066292A1/es unknown
- 2008-04-29 TW TW097115670A patent/TW200900056A/zh unknown
- 2008-04-29 UY UY31061A patent/UY31061A1/es not_active Application Discontinuation
- 2008-04-30 CL CL2008001259A patent/CL2008001259A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20100014486A (ko) | 2010-02-10 |
BRPI0811007A2 (pt) | 2015-01-27 |
AU2008248043A1 (en) | 2008-11-13 |
EP2139471A2 (en) | 2010-01-06 |
AR066292A1 (es) | 2009-08-12 |
US20080269318A1 (en) | 2008-10-30 |
CN101674824A (zh) | 2010-03-17 |
MX2009009738A (es) | 2009-09-24 |
CL2008001259A1 (es) | 2009-01-02 |
JP2010526074A (ja) | 2010-07-29 |
RU2009144142A (ru) | 2011-06-10 |
WO2008137236A3 (en) | 2009-02-05 |
TW200900056A (en) | 2009-01-01 |
WO2008137236A2 (en) | 2008-11-13 |
CA2680833A1 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31061A1 (es) | Tratamiento de la degeneracion macular relacionada con la edad mediante el uso de inhibidores del factor d del complemento | |
CY1124307T1 (el) | Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων | |
PA8637201A1 (es) | Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa | |
CY1121203T1 (el) | Θεραπευτικες χρησεις της εμπαγλιφλοζινης | |
EA201101037A1 (ru) | Лечение диабета у пациентов с неадекватным гликемическим контролем, несмотря на лечение метформином | |
AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
UY31497A1 (es) | Nuevos compuestos para el tratamiento de trastornos del snc | |
ECSP11010971A (es) | Tratamiento de la diabetes en pacientes con control glucemico insuficiente a pesar de la terapia con un fármaco oral o no oral antidiabético | |
CY1117603T1 (el) | Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2 | |
CY1116064T1 (el) | Συστασεις αναστολεα ddp iv | |
CL2012002526A1 (es) | Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca. | |
CL2015002641A1 (es) | Método para el tratamiento de la enfermedad de parkinson. | |
CO6390109A2 (es) | Inhibidores de syk de imidazopirazina | |
PA8637301A1 (es) | Derivados de amino-5, 5-difenilimidazolona para la inhibicion de la b-secretasa | |
UY30846A1 (es) | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos | |
PA8841701A1 (es) | Derivados heterocíclicos, procesos para su preparación, medicamentos que comprenden compuestos y su uso | |
ES2689971T3 (es) | Uso de inhibidores de PDE7 para el tratamiento de los trastornos del movimiento | |
AR060278A1 (es) | Tratamientos de las alergias oculares | |
AR058749A1 (es) | Inhibidores de c3-convertasa para la prevencion y el tratamiento de la degeneracion macular relacionada con la edad en pacientes con variantes de riesgo de factor h de complemento | |
ECSP099556A (es) | Nuevos métodos | |
CY1119867T1 (el) | Αναστολεις vap-1 για χρηση στη θεραπεια ινωτικων καταστασεων | |
CY1112414T1 (el) | Υλικα οφθαλμικων και ωτορινολαρυγγολογικων συσκευων | |
AR054357A1 (es) | Metodo para evaluar la efectividad de un regimen de tratamiento | |
AR086395A1 (es) | Envase para el tratamiento de patologias | |
CY1117674T1 (el) | Χρηση παραγωγων των orvinol και thevinol ως θεραπευτικη αγωγη στην καταχρηση αλκοολ και φαρμακων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20190902 |